Success Stories: Our NIW Client from India Gets NIW Confirmation in Just 2 Months and 11 Days While Working as a Research Scientist in Biochemistry

Client’s Testimonial:

“It was really pleasant to hear that NIW I-140 is approved. It is pretty fast and thanks for your help in this process.”

On April 22^nd, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist II in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Research Scientist II

Country of Origin: India

State of Residence at the Time of Filing: Texas

Approval Notice Date: April 22^nd, 2022

Processing Time: 2 months, 11 days

Case Summary:

An Indian expert in the field of biochemistry became our client while working as a research scientist in the field. He wanted to apply for a National Interest Waiver (NIW) with our help. Since the USCIS demands NIW applicants to show how their work is of importance to the country, our team ensured this by putting together a customized application containing the following information collected from his academic and professional documents:

His proposed endeavor is to continue his research on DNA damage, innate inflammation, and DNA repair mechanisms in mammalian cells in order to decipher the intricacies of mammalian DNA repair pathways and identify the repair deficiencies underlying neurodegenerative conditions, inflammatory diseases, and cancer, thereby supporting the development of mechanism-based therapeutic strategies for such conditions.
His research advancing his proposed endeavor is of great importance because it optimizes mechanism-based therapeutic strategies for neurodegenerative conditions, inflammatory diseases, and cancer.
His proposed endeavor also had broad implications for the United States as neurodegenerative conditions, such as Alzheimer’s disease, Huntington’s disease, and spinocerebellar ataxia, affect as many as 6 million Americans.
Due to its clear national importance, his research has in fact been supported with funding from the National Institutes of Health and the Department of Defense.
He has been regularly invited to conduct peer reviews for authoritative journals in the field, including international journals. We found that he has completed at least 30 reviews to date.
His research has been published as 28 peer-reviewed journal articles (6 of them first-authored or co-first authored), and 3 press book chapters (1 of them first-authored).
And these publications have been cited a total of 618 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biochemistry.
We also added detailed descriptions of 5 of his key projects as evidence of his contributions to and expertise in the field of biochemistry.
We also provided evidence of his membership on the editorial board as a Review Editor for multiple scientific journals related to his field of work.
Finally, we attached 2 letters of recommendation collected from other experts in the group.

These pieces of evidence were arranged in form of a well-written petition letter and presented for adjudication at the USCIS. We made sure to show that our client was uniquely well-positioned to pursue his research work considering the breadth of his many years of experience as well as his leadership and expertise in the field.

All of these factors combined made for a strong case and won him the NIW approval only 2 months and 11 days later. We are grateful to him for choosing us to represent him.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.